Latest Breaking News On - Norwich pharmaceuticals - Page 5 : comparemela.com
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Christina Siniscalchi will join its corporate leadership team as interim Chief Quality Officer. Christina succeeds Sandra Casaca, who is leaving the company as a part of other organizational changes. Christina Siniscalchi has for over ten years served in senior quality positions for Alvogen and its manufacturing site in Norwich, NY
UkraineTaiwanAustraliaUnited-kingdomMalaysiaBangladeshSwitzerlandPhilippinesIndonesiaCambodiaIndiaNew-zealandREYKJAVIK, Iceland, Feb. 29, 2024 (GLOBE NEWSWIRE) Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Christina Siniscalchi will join its corporate leadership team as interim Chief Quality Officer. Christina succeeds Sandra Casaca, who is leaving the company as a part of other organizational changes. Christina Siniscalchi has for over ten years served in senior quality positions
UkraineHong-kongJapanSingaporeYangtze-riverChina-generalChinaIndonesiaAustraliaCanadaNew-zealandTaiwan